Related references
Note: Only part of the references are listed.Hepatitis B vaccines: WHO position paper, July 2017-Recommendations
VACCINE (2019)
Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection
H. R. Gurung et al.
MUCOSAL IMMUNOLOGY (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Nasopharyngeal carcinoma: A review of current updates
Lei Wu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+T cells
Sanaz Baghban Rahimi et al.
ARCHIVES OF VIROLOGY (2018)
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study
Janet S. Rader et al.
GYNECOLOGIC ONCOLOGY (2017)
Epstein-Barr virus-associated lymphomas
Claire Shannon-Lowe et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells
Yu-Yun Shao et al.
ONCOTARGET (2017)
Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B
Takuto Nosaka et al.
PLOS ONE (2017)
New Therapeutic Perceptions in a Patient with Complicated Herpes Simplex Virus 1 Keratitis: A Case Report and Review of the Literature
Dimitrios Kalogeropoulos et al.
AMERICAN JOURNAL OF CASE REPORTS (2017)
The role of Nuclear Factor-kappa B signaling in human cervical cancer
Sam Tilborghs et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Phase II randomized trial of radiation therapy, cetuximab, and pemetrexed with or without bevacizumab in patients with locally advanced head and neck canceraEuro
A. Argiris et al.
ANNALS OF ONCOLOGY (2016)
Effect of Vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome
Brian H. Bird et al.
ANTIVIRAL RESEARCH (2016)
Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi
Ellen Krautkraemer et al.
BMC INFECTIOUS DISEASES (2016)
Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells
Wei-Wen Sung et al.
CANCER LETTERS (2016)
Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma
T. Vescovo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland
Lesley A. Anderson et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
VEGF receptor signal transduction - A brief update
Lena Claesson-Welsh
VASCULAR PHARMACOLOGY (2016)
Short-term treatment of equine wounds with orf virus IL-10 and VEGF-E dampens inflammation and promotes repair processes without accelerating closure
Christa J. Bodaan et al.
WOUND REPAIR AND REGENERATION (2016)
Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections
Malgorzata Polz-Dacewicz et al.
INFECTIOUS AGENTS AND CANCER (2016)
Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma
Scott V. Bratman et al.
JAMA ONCOLOGY (2016)
CANCER PREVENTION: HPV VACCINATION
Tami L. Thomas
SEMINARS IN ONCOLOGY NURSING (2016)
Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A
Karin B. Sundstrom et al.
PLOS ONE (2016)
The kinase-inhibitor sorafenib inhibits multiple steps of the Hepatitis C Virus infectious cycle in vitro
Veronique Descamps et al.
ANTIVIRAL RESEARCH (2015)
Influence of vascular endothelial growth factor and alpha-fetoprotein on hepatocellular carcinoma
E. Y. Yvamoto et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Hantaviruses-Globally emerging pathogens
Detlev H. Kruger et al.
JOURNAL OF CLINICAL VIROLOGY (2015)
A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
Yu Yang et al.
LIVER INTERNATIONAL (2015)
Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells
Fang Li et al.
MEDICAL ONCOLOGY (2015)
Corneal lymphangiogenesis in herpetic stromal keratitis
Paul J. Park et al.
SURVEY OF OPHTHALMOLOGY (2015)
Molecular Genetic Analysis of Orf Virus: A Poxvirus That Has Adapted to Skin
Stephen B. Fleming et al.
VIRUSES-BASEL (2015)
EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma
Lifang Yang et al.
ONCOTARGET (2015)
The evolution and emergence of hantaviruses
Edward C. Holmes et al.
CURRENT OPINION IN VIROLOGY (2015)
Oncogenic potential of hepatitis B virus encoded proteins
Marc Ringelhan et al.
CURRENT OPINION IN VIROLOGY (2015)
Su2042 Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
Takanori Mukozu et al.
GASTROENTEROLOGY (2015)
The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets
Marc Ringelhan et al.
JOURNAL OF PATHOLOGY (2015)
New insights into the immunopathology and control of dengue virus infection
Gavin Screaton et al.
NATURE REVIEWS IMMUNOLOGY (2015)
HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinoma
L-p Liu et al.
BRITISH JOURNAL OF CANCER (2014)
Serum angiopoietin-2 and soluble VEGF receptor 2 are surrogate markers for plasma leakage in patients with acute dengue virus infection
Cornella A. M. van de Weg et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Cathy Ndiaye et al.
LANCET ONCOLOGY (2014)
Hepatitis C virus core protein induces hypoxia-inducible factor 1α-mediated vascular endothelial growth factor expression in Huh7.5.1 cells
Chengliang Zhu et al.
MOLECULAR MEDICINE REPORTS (2014)
Novel therapy for nasopharyngeal carcinoma - Where are we
Janice Tsang et al.
ORAL ONCOLOGY (2014)
mTOR Inhibitors Block Kaposi Sarcoma Growth by Inhibiting Essential Autocrine Growth Factors and Tumor Angiogenesis
Debasmita Roy et al.
CANCER RESEARCH (2013)
Hypoxia Induces Permeability and Giant Cell Responses of Andes Virus-Infected Pulmonary Endothelial Cells by Activating the mTOR-S6K Signaling Pathway
Irina N. Gavrilovskaya et al.
JOURNAL OF VIROLOGY (2013)
Role of Vascular and Lymphatic Endothelial Cells in Hantavirus Pulmonary Syndrome Suggests Targeted Therapeutic Approaches
Erich R. Mackow et al.
LYMPHATIC RESEARCH AND BIOLOGY (2013)
Antiangiogenic Therapies for Advanced Hepatocellular Carcinoma
Keeran R. Sampat et al.
ONCOLOGIST (2013)
Epigenetic regulation of EBV and KSHV latency
Horng-Shen Chen et al.
CURRENT OPINION IN VIROLOGY (2013)
Role of miR-132 in Angiogenesis after Ocular Infection with Herpes Simplex Virus
Sachin Mulik et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions
Mitsuhiko Abe et al.
HEPATOLOGY RESEARCH (2012)
A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor
Yuan Mao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer
P. M. Biselli-Chicote et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
IL-17A Differentially Regulates Corneal Vascular Endothelial Growth Factor (VEGF)-A and Soluble VEGF Receptor 1 Expression and Promotes Corneal Angiogenesis after Herpes Simplex Virus Infection
Amol Suryawanshi et al.
JOURNAL OF IMMUNOLOGY (2012)
Elevated Vascular Endothelial Growth Factor Levels Induce Hyperpermeability of Endothelial Cells in Hantavirus Infection
Y. Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
Nancy Y. Lee et al.
LANCET ONCOLOGY (2012)
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling
Rui Benedito et al.
NATURE (2012)
Hepatitis B Virus X Protein Upregulates mTOR Signaling through IKKβ to Increase Cell Proliferation and VEGF Production in Hepatocellular Carcinoma
Chia-Jui Yen et al.
PLOS ONE (2012)
Association of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome
Takahisa Furuta et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile
Weihua Tang et al.
INFECTIOUS AGENTS AND CANCER (2012)
Signal transduction by vascular endothelial growth factor receptors
Sina Koch et al.
BIOCHEMICAL JOURNAL (2011)
Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1 α and VEGF expression in non-small cell lung cancer cells
Gang Li et al.
CANCER LETTERS (2011)
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA
Hashem B. El-Serag et al.
GUT (2011)
Ocular Neovascularization Caused by Herpes Simplex Virus Type 1 Infection Results from Breakdown of Binding between Vascular Endothelial Growth Factor A and Its Soluble Receptor
Amol Suryawanshi et al.
JOURNAL OF IMMUNOLOGY (2011)
VEGFR2 and Src Kinase Inhibitors Suppress Andes Virus-Induced Endothelial Cell Permeability
Elena E. Gorbunova et al.
JOURNAL OF VIROLOGY (2011)
Deletion of Kaposi's Sarcoma-Associated Herpesvirus FLICE Inhibitory Protein, vFLIP, from the Viral Genome Compromises the Activation of STAT1-Responsive Cellular Genes and Spindle Cell Formation in Endothelial Cells
Khaled R. Alkharsah et al.
JOURNAL OF VIROLOGY (2011)
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
Tuomas Tammela et al.
NATURE CELL BIOLOGY (2011)
The Herpes Simplex Virus-1 Transactivator Infected Cell Protein-4 Drives VEGF-A Dependent Neovascularization
Todd Wuest et al.
PLOS PATHOGENS (2011)
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis
Todd R. Wuest et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2010)
Pathogenic Hantaviruses Andes Virus and Hantaan Virus Induce Adherens Junction Disassembly by Directing Vascular Endothelial Cadherin Internalization in Human Endothelial Cells
Elena Gorbunova et al.
JOURNAL OF VIROLOGY (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication
K. Himmelsbach et al.
GUT (2009)
Enhanced Expression of Vascular Endothelial Growth Factor-A in Ground Glass Hepatocytes and Its Implication in Hepatitis B Virus Hepatocarcinogenesis
Jui-Chu Yang et al.
HEPATOLOGY (2009)
Gene Regulation and Functional Alterations Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORFK13/vFLIP in Endothelial Cells
Shuhei Sakakibara et al.
JOURNAL OF VIROLOGY (2009)
The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus
Zu-Bing Chen et al.
MEDICAL ONCOLOGY (2009)
Profile of time-dependent VEGF upregulation in human pulmonary endothelial cells, HPMEC-ST1.6R infected with DENV-1,-2,-3, and-4 viruses
Azliyati Azizan et al.
VIROLOGY JOURNAL (2009)
Treatment of hantavirus pulmonary syndrome
Colleen B. Jonsson et al.
ANTIVIRAL RESEARCH (2008)
VEGF receptor protein-tyrosine kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1α to induce vascular endothelial growth factor expression
Young C. Shin et al.
CANCER RESEARCH (2008)
Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR
Stephanie Cebe-Suarez et al.
FASEB JOURNAL (2008)
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro
John D. O'Neil et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats
Judith D. Easterbrook et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability
Irina N. Gavrilovskaya et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling
Tatsuo Kanda et al.
JOURNAL OF VIROLOGY (2008)
Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas
Semra Paydas et al.
LEUKEMIA RESEARCH (2008)
Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells
Y-G Yoo et al.
ONCOGENE (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Major amino acid sequence variants of viral vascular endothelial growth factor are functionally equivalent during Orf virus infection of sheep skin
Lyn M. Wise et al.
VIRUS RESEARCH (2007)
Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IκB kinase complex to selectively activate NF-κB without JNK activation
Hittu Matta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1α protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells
Xudong Tang et al.
CLINICAL CANCER RESEARCH (2007)
Bovine papular stomatitis virus encodes a functionally distinct VEGF that binds both VEGFR-1 and VEGFR-2
Marie K. Inder et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Parapoxvirus of red deer in New Zealand encodes a variant of viral vascular endothelial growth factor
Norihito Ueda et al.
VIRUS RESEARCH (2007)
Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever
Anon Srikiatkhachorn et al.
JOURNAL OF VIROLOGY (2007)
Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes
Natsuo Inoue et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced Kaposi's sarcoma
Agata D'Agostino Mutlu et al.
CANCER CELL (2007)
Differential proinflammatory and angiogenesis-specific cytokine production in human pulmonary endothelial cells, HPMEC-ST1.6R infected with dengue-2 and dengue-3 virus
Azliyati Azizan et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Localization of heparin- and neuropilin-1-recognition sites of viral VEGFs
Yuko Tokunaga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Activation of NF-κB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype
Claudia Grossmann et al.
JOURNAL OF VIROLOGY (2006)
Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo
Feng-Qi An et al.
JOURNAL OF VIROLOGY (2006)
Discovery of vascular permeability factor (VPF)
HF Dvorak
EXPERIMENTAL CELL RESEARCH (2006)
Chimeric VEGF-E-NZ7/PIGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation
Yujuan Zheng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status
SM Krishna et al.
VIRUS RESEARCH (2006)
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection
PS Biswas et al.
EXPERIMENTAL EYE RESEARCH (2006)
Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGFα concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9
D Stevenson et al.
CANCER RESEARCH (2005)
The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma
RB Guerrero et al.
JOURNAL OF HEPATOLOGY (2005)
Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever
CS Tseng et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors
KE Hamden et al.
LEUKEMIA (2005)
Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors
E Toussaint-Smith et al.
ONCOGENE (2004)
The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors
L Wang et al.
CANCER RESEARCH (2004)
Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression
J Vieira et al.
VIROLOGY (2004)
Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma
L Messerini et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes - Therapeutic strategy for herpetic stromal keratitis
B Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1α through activation of mitogen-activated protein kinase pathway
YG Yoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
KSHV vFLIP binds to IKK-γ to activate IKK
N Field et al.
JOURNAL OF CELL SCIENCE (2003)
Vascular endothelial growth factor receptor-2: Its unique signaling and specific ligand, VEGF-E
M Shibuya
CANCER SCIENCE (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Pseudocowpox virus encodes a homolog of vascular endothelial growth factor
N Ueda et al.
VIROLOGY (2003)
Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review
JS Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis
M Zheng et al.
JOURNAL OF VIROLOGY (2001)
Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells
S Murono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma
GW Huang et al.
LARYNGOSCOPE (2000)
Viral vascular endothelial growth factor plays a critical role in orf virus infection
LJ Savory et al.
JOURNAL OF VIROLOGY (2000)
Oncogenes and tumor angiogenesis:: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
O López-Ocejo et al.
ONCOGENE (2000)
Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis
SW Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis
S Song et al.
VIROLOGY (2000)
Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma
TY Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
